- Home
- POM vs TXO Comparison
POM vs TXO Comparison
Compare POM & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POM
- TXO
- Stock Information
- Founded
- POM 2015
- TXO 2012
- Country
- POM China
- TXO United States
- Employees
- POM N/A
- TXO N/A
- Industry
- POM Other Specialty Stores
- TXO Oil & Gas Production
- Sector
- POM Consumer Discretionary
- TXO Energy
- Exchange
- POM Nasdaq
- TXO Nasdaq
- Market Cap
- POM 640.8M
- TXO 701.2M
- IPO Year
- POM 2025
- TXO 2023
- Fundamental
- Price
- POM $5.82
- TXO $13.18
- Analyst Decision
- POM
- TXO Strong Buy
- Analyst Count
- POM 0
- TXO 2
- Target Price
- POM N/A
- TXO $20.50
- AVG Volume (30 Days)
- POM 3.2M
- TXO 201.6K
- Earning Date
- POM 01-01-0001
- TXO 11-05-2025
- Dividend Yield
- POM N/A
- TXO 18.16%
- EPS Growth
- POM N/A
- TXO N/A
- EPS
- POM N/A
- TXO 0.30
- Revenue
- POM $46,931,528.00
- TXO $332,267,000.00
- Revenue This Year
- POM N/A
- TXO $32.13
- Revenue Next Year
- POM N/A
- TXO $11.48
- P/E Ratio
- POM N/A
- TXO $44.63
- Revenue Growth
- POM 12.37
- TXO 15.94
- 52 Week Low
- POM $3.47
- TXO $12.61
- 52 Week High
- POM $5.67
- TXO $20.70
- Technical
- Relative Strength Index (RSI)
- POM N/A
- TXO 43.25
- Support Level
- POM N/A
- TXO $13.02
- Resistance Level
- POM N/A
- TXO $13.30
- Average True Range (ATR)
- POM 0.00
- TXO 0.32
- MACD
- POM 0.00
- TXO 0.03
- Stochastic Oscillator
- POM 0.00
- TXO 61.36
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.